Effects of Combined Music and Exercise Therapy on Depression: A Systematic Review and Meta-Analysis.

J Integr Complement MedFeb 4, 2026 (epub)
Clinical ResearchPsychiatry

Xiaoqin Luo, Xingyue Zhang, Carmelo Mario Vicario et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis assessed randomized controlled trials of combined music and exercise therapy for people with mild, moderate, or severe depression. Seven trials involving 640 patients were included. Compared with control conditions or other treatments, the combined intervention was associated with a significant reduction in depressive symptoms (SMD = -0.49, 95% CI: -0.93 to -0.06, p = 0.03). Subgroup findings favored music paired with Tai Chi or aerobic exercise, particularly among patients older than 60 years. The authors caution that heterogeneity and varying risk of bias limit confidence in the evidence.

Key findings

  • Across seven trials and 640 patients, combined music and exercise reduced depressive symptoms (SMD = -0.49, 95% CI: -0.93 to -0.06, p = 0.03).
  • Music paired with Tai Chi (SMD = -0.96, 95% CI: -1.90 to -0.02, p = 0.04) or aerobic exercise (SMD = -0.60, 95% CI: -0.98 to -0.23, p = 0.001) showed significant subgroup effects.
  • In patients older than 60 years, the subgroup effect was SMD = -0.31, 95% CI: -0.61 to -0.01, p = 0.04.
  • Two studies reported transient fatigue; no withdrawals were attributed to adverse events.

Why it matters

The findings suggest that pairing music with exercise may be a tolerable non-pharmacological option associated with reduced depressive symptoms. The subgroup results offer a basis for further evaluation of specific exercise formats and older populations, but the evidence does not establish which patients are most likely to benefit or whether the effect is robust across settings.

What to keep in mind

The authors report heterogeneity and varying risk of bias among the included studies, limiting the quality of the evidence.

Source

Published in J Integr Complement Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.